Protalix BioTherapeutics (PLX) Other financing activities (2010 - 2016)
Protalix BioTherapeutics (PLX) posted quarterly Other financing activities of $14000.0 for Q4 2016, down 54.84% quarter-over-quarter from $31000.0 in Q1 2014.
Protalix BioTherapeutics (PLX) Other financing activities (2010 - 2016) Analysis & Trends
Protalix BioTherapeutics' Other financing activities history runs 6 years deep, the most recent figure standing at $14000.0 for Q4 2016.
- In Q4 2016, Other financing activities changed N/A year-over-year to $14000.0; the TTM figure through Dec 2022 stood at $14000.0 (changed N/A YoY), while the FY2023 annual figure was $712000.0, up 35500.0% from the prior year.
- Other financing activities for Q4 2016 stood at $14000.0, down from $31000.0 in the prior quarter.
- The five-year high for Other financing activities was $1.0 million in Q2 2012, with the low at $2000.0 in Q2 2013.
- The 4-year median for Other financing activities is $31000.0 (2014), against an average of $154111.1.
- The sharpest annual moves came in 2012 and 2013: Other financing activities surged 34900.0% in 2012, then sank 99.81% in 2013.
- Protalix BioTherapeutics' Other financing activities stood at $134000.0 in 2012, then sank by 38.81% to $82000.0 in 2013, then plunged by 62.2% to $31000.0 in 2014, then sank by 54.84% to $14000.0 in 2016.
- Business Quant data shows PLX's Other financing activities at $14000.0 in Q4 2016, $31000.0 in Q1 2014, and $82000.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Protalix BioTherapeutics | 190.37 Mn | 149.71 Mn | 12.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 14,000.00 |
| Dec 31, 2016 | 14,000.00 |
| Mar 31, 2014 | 31,000.00 |
| Mar 31, 2014 | 31,000.00 |
| Dec 31, 2013 | 82,000.00 |
| Dec 31, 2013 | 82,000.00 |
| Jun 30, 2013 | 2,000.00 |
| Jun 30, 2013 | 2,000.00 |
| Mar 31, 2013 | 28,000.00 |
| Mar 31, 2013 | 28,000.00 |
| Dec 31, 2012 | 134,000.00 |
| Dec 31, 2012 | 134,000.00 |
| Sep 30, 2012 | 10,000.00 |
| Sep 30, 2012 | 10,000.00 |
| Jun 30, 2012 | 1.05 Mn |
| Jun 30, 2012 | 1.05 Mn |
| Mar 31, 2012 | 36,000.00 |
| Mar 31, 2012 | 36,000.00 |
| Dec 31, 2011 | 14,000.00 |
| Dec 31, 2011 | 14,000.00 |